{
  "meta": {
    "title": "Paraneoplastic_Syndromes_-_Part_2",
    "url": "https://brainandscalpel.vercel.app/paraneoplastic-syndromes-part-2-c4e220f9.html",
    "scrapedAt": "2025-11-29T18:25:03.078Z"
  },
  "questions": [
    {
      "id": 19830,
      "choices": [
        {
          "id": 79281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cortical encephalitis</span></span></span></p>"
        },
        {
          "id": 79282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Limbic encephalitis</span></span></span></p>"
        },
        {
          "id": 79283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cerebellar encephalitis</span></span></span></p>"
        },
        {
          "id": 79284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brainstem encephalitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman presents to the clinic with a 2-month history of progressive memory loss, confusion, and episodes of hallucinations. Her family also reports a change in her behavior, describing her as increasingly irritable and sometimes displaying inappropriate emotional responses. She was recently diagnosed with lung cancer. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q2388852",
      "question_audio": null,
      "question_video": null,
      "map_id": 19741,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Limbic encephalitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Limbic encephalitis is a type of autoimmune encephalitis that affects the limbic system, which includes structures such as the hippocampus, amygdala, and parts of the frontal and temporal lobes. These areas are involved in memory, emotion, and behavior. Limbic encephalitis often presents with subacute (developing over weeks to months) symptoms of memory loss, confusion, seizures, and behavioral changes, including irritability and inappropriate emotional responses. Hallucinations, both visual and auditory, can also be a feature. The association with lung cancer, especially small cell lung cancer, suggests a paraneoplastic etiology, where the body&#39;s immune response against the tumor also targets similar antigens expressed in the nervous system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Cortical encephalitis:</strong> Would involve more widespread cerebral cortex symptoms, including significant changes in cognition, motor, and sensory functions but might not specifically target memory and emotional regulation as in limbic encephalitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Cerebellar encephalitis:</strong> Would primarily affect coordination, gait, and balance due to inflammation of the cerebellum, and would be less likely to cause the memory and behavioral symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Brainstem encephalitis:</strong> Would involve symptoms related to the functions of the brainstem, including vital functions, cranial nerve functions, and coordination, rather than primarily memory and behavior.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Limbic encephalitis presents with progressive memory loss, confusion, behavioral changes, and sometimes hallucinations due to the involvement of the limbic system. It can be associated with lung cancer as a paraneoplastic syndrome, where the immune system&#39;s response to the cancer also affects the nervous system.</span></span></p>",
      "correct_choice_id": 79282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19831,
      "choices": [
        {
          "id": 79285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Corticosteroids and intravenous immunoglobulin (IVIG) or plasma exchange </span></span></span></p>"
        },
        {
          "id": 79286,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antiepileptic drugs only </span></span></span></p>"
        },
        {
          "id": 79287,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chemotherapy for ovarian cancer </span></span></span></p>"
        },
        {
          "id": 79288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Radiation therapy to the brain</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman with a recent diagnosis of ovarian cancer is brought to the emergency department due to altered mental status, memory loss, and involuntary movements. Her family reports that she has also been experiencing seizures. Further evaluation reveals anti-NMDA receptor antibodies in her serum. Which of the following is the most appropriate initial treatment for this patient&#39;s condition?</span></span></p>",
      "unique_key": "Q3929564",
      "question_audio": null,
      "question_video": null,
      "map_id": 19743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Corticosteroids and intravenous immunoglobulin (IVIG) or plasma exchange</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation and the presence of anti-NMDA receptor antibodies strongly suggest anti-NMDA receptor encephalitis, a paraneoplastic syndrome often associated with ovarian teratomas. The most appropriate initial treatment for this condition is immunotherapy, which includes corticosteroids and either IVIG or plasma exchange to remove the pathogenic antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Antiepileptic drugs only:</span></strong><span style=\"font-size:12.0pt\"> While antiepileptic drugs are necessary to manage seizures, they do not address the underlying autoimmune process.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chemotherapy for ovarian cancer:</span></strong><span style=\"font-size:12.0pt\"> While treating the underlying cancer is important, immediate immunotherapy is crucial to control the neurological symptoms and prevent further brain damage.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Radiation therapy to the brain:</span></strong><span style=\"font-size:12.0pt\"> Radiation therapy is not the primary treatment for anti-NMDA receptor encephalitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-NMDA receptor encephalitis is a potentially reversible autoimmune disorder that requires prompt recognition and treatment with immunotherapy.</span></span></p>",
      "correct_choice_id": 79285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19841,
      "choices": [
        {
          "id": 79325,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibodies against intracellular antigens are almost always paraneoplastic. </span></span></span></p>"
        },
        {
          "id": 79326,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibodies against cell surface antigens can be autoimmune and may not always be associated with cancer. </span></span></span></p>"
        },
        {
          "id": 79327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibodies can be detected in both CSF and serum. </span></span></span></p>"
        },
        {
          "id": 79328,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of antibodies in CSF excludes an autoimmune cause.</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements regarding antibodies in paraneoplastic neurological syndromes (PNS) is FALSE?</span></span></p>",
      "unique_key": "Q4174462",
      "question_audio": null,
      "question_video": null,
      "map_id": 19794,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) The presence of antibodies in CSF excludes an autoimmune cause.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antibodies can be present in CSF in both paraneoplastic and autoimmune neurological disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antibodies against intracellular antigens are almost always paraneoplastic:</span></strong><span style=\"font-size:12.0pt\"> This is generally true. Antibodies targeting intracellular antigens, such as Hu, Yo, or Ri, are highly suggestive of a paraneoplastic neurological syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Antibodies against cell surface antigens can be autoimmune and may not always be associated with cancer:</span></strong><span style=\"font-size:12.0pt\"> This is also accurate. Some antibodies target cell surface antigens, and these can be associated with autoimmune conditions without an underlying malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Antibodies can be detected in both CSF and serum:</span></strong><span style=\"font-size:12.0pt\"> This is correct. In PNS, the antibodies can often be found in both the cerebrospinal fluid (CSF) and the serum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of antibodies in CSF does not differentiate between paraneoplastic and autoimmune causes.</span></span></span></p>",
      "correct_choice_id": 79328,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19842,
      "choices": [
        {
          "id": 79329,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Hu </span></span></span></p>"
        },
        {
          "id": 79330,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Yo </span></span></span></p>"
        },
        {
          "id": 79331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ANNA-2</span></span></span></p>"
        },
        {
          "id": 79332,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Ma2</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman with a BG of CA Breast on chemotherapy presents with progressive ataxia and opsoclonus (rapid, multidirectional eye movements). Which antibody is MOST likely to be found in her serum?</span></span></p>",
      "unique_key": "Q7379324",
      "question_audio": null,
      "question_video": null,
      "map_id": 19795,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) ANNA - 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of cerebellar ataxia (difficulty with coordination and balance) and opsoclonus (rapid, involuntary eye movements in various directions) is highly characteristic of a paraneoplastic neurological syndrome associated with <strong>anti-Ri antibodies (also known as ANNA-2)</strong>. While paraneoplastic neurological syndromes can occur with various cancers, the presence of these specific symptoms and antibodies in a patient with breast cancer makes anti-Ri the most likely answer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anti-Hu:</span></strong><span style=\"font-size:12.0pt\"> Anti-Hu antibodies are associated with paraneoplastic encephalomyelitis and sensory neuronopathy, which typically present with sensory loss, limb weakness, and autonomic dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anti-Yo:</span></strong><span style=\"font-size:12.0pt\"> Anti-Yo antibodies are linked to paraneoplastic cerebellar degeneration, causing ataxia, but not typically opsoclonus. They are more commonly associated with gynecological and breast cancers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anti-Ma2:</span></strong><span style=\"font-size:12.0pt\"> Anti-Ma2 antibodies are associated with limbic encephalitis and brainstem encephalitis, which usually present with psychiatric symptoms, seizures, and sometimes brainstem dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Certain antibodies are highly associated with specific paraneoplastic neurological syndromes.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, the presence of ataxia and opsoclonus, particularly in a patient with breast cancer, points strongly toward anti-Ri antibodies.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognizing these paraneoplastic syndromes is crucial for early diagnosis and appropriate management.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 79331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19843,
      "choices": [
        {
          "id": 79333,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Hu antibodies </span></span></span></p>"
        },
        {
          "id": 79334,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-Yo antibodies </span></span></span></p>"
        },
        {
          "id": 79335,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-recoverin antibodies </span></span></span></p>"
        },
        {
          "id": 79336,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-amphiphysin antibodies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman with a history of small cell lung cancer (SCLC) presents with unexplained vision loss and abnormal retinal pigmentation. Which of the following antibodies is MOST likely associated with her suspected diagnosis?</span></span></p>",
      "unique_key": "Q4810003",
      "question_audio": null,
      "question_video": null,
      "map_id": 19796,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Anti-recoverin antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of vision loss and retinal changes in a patient with SCLC is highly suggestive of <strong>cancer-associated retinopathy (CAR)</strong>. This is a paraneoplastic syndrome where the body&#39;s immune system mistakenly attacks retinal proteins, leading to vision impairment. <strong>Anti-recoverin antibodies</strong> are the most commonly detected antibodies in patients with CAR.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Anti-Hu antibodies:</span></strong><span style=\"font-size:12.0pt\"> These antibodies are associated with paraneoplastic encephalomyelitis and sensory neuronopathy, which typically present with neurological symptoms like ataxia, sensory loss, and autonomic dysfunction, not primarily vision loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anti-Yo antibodies:</span></strong><span style=\"font-size:12.0pt\"> Anti-Yo antibodies are linked to paraneoplastic cerebellar degeneration, causing ataxia but not typically vision loss.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anti-amphiphysin antibodies:</span></strong><span style=\"font-size:12.0pt\"> These antibodies are associated with stiff person syndrome, a rare neurological disorder characterized by muscle rigidity and spasms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cancer-associated retinopathy is a paraneoplastic syndrome that can cause vision loss in patients with underlying malignancies, particularly SCLC.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-recoverin antibodies are highly specific for CAR and their presence can help confirm the diagnosis.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 79335,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19844,
      "choices": [
        {
          "id": 79337,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-mGluR1</span></span></p>"
        },
        {
          "id": 79338,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-mGluR2</span></span></p>"
        },
        {
          "id": 79339,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-Tr</span></span></p>"
        },
        {
          "id": 79340,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti LGI1</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man with recent diagnosis of Hodgkin&#39;s lymphoma presents to neurology clinic with a 3-month history of progressive unsteadiness and difficulty walking. He reports feeling clumsy and has noticed frequent stumbling, particularly when trying to navigate stairs. Additionally, he mentions episodes of slurred speech and difficulty swallowing. Given the presentation, which of the following antibodies is not involved in the condition?</span></span></p>",
      "unique_key": "Q1869533",
      "question_audio": null,
      "question_video": null,
      "map_id": 19797,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Anti LGI1</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-LGI1 (Leucine-rich glioma inactivated 1) antibodies are associated with limbic encephalitis, not paraneoplastic cerebellar degeneration. Patients with Anti-LGI1 antibodies typically present with cognitive impairment, seizures, and psychiatric symptoms, which are distinct from the cerebellar symptoms described in this patient&#39;s presentation. Therefore, Anti-LGI1 antibodies are not involved in the condition suggested by this patient&#39;s clinical presentation and recent diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s symptoms of progressive unsteadiness, difficulty walking, slurred speech, and difficulty swallowing, in the context of a recent diagnosis of Hodgkin&#39;s lymphoma, suggest a paraneoplastic neurological syndrome. Specifically, the symptoms are indicative of paraneoplastic cerebellar degeneration (PCD), which can be associated with Hodgkin&#39;s lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: &nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A.</strong> <strong>Anti-mGluR1</strong>: Antibodies are associated with paraneoplastic cerebellar degeneration, especially in cases related to Hodgkin&#39;s lymphoma. These antibodies target the metabotropic glutamate receptor 1, which is involved in neuronal signaling in the cerebellum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B.</strong> <strong>Anti-mGluR2</strong>: Antibodies target the metabotropic glutamate receptor 2. While less commonly associated with PCD, they have been implicated in some paraneoplastic neurological syndromes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C.</strong> <strong>Anti-Tr:</strong> Antibodies are strongly associated with paraneoplastic cerebellar degeneration, particularly in patients with Hodgkin&#39;s lymphoma. They are one of the hallmark antibodies for this association.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Paraneoplastic cerebellar degeneration (PCD) associated with Hodgkin&#39;s lymphoma is commonly linked with Anti-mGluR1 and Anti-Tr antibodies, which target neuronal components in the cerebellum. In contrast, Anti-LGI1 antibodies are associated with limbic encephalitis and present with a different clinical picture, including seizures and cognitive changes, rather than the cerebellar dysfunction seen in PCD.</span></span></p>",
      "correct_choice_id": 79340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19845,
      "choices": [
        {
          "id": 79341,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Renal cell carcinoma (RCC) </span></span></span></p>"
        },
        {
          "id": 79342,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hepatocellular carcinoma (HCC) </span></span></span></p>"
        },
        {
          "id": 79343,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cerebellar hemangioblastoma </span></span></span></p>"
        },
        {
          "id": 79344,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Small cell lung cancer (SCLC)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old male smoker with a 50-pack-year history presents with fatigue and a ruddy complexion. His hemoglobin is elevated at 18 g/dL and hematocrit is 55%. Which of the following malignancies is the MOST likely underlying cause of his erythrocytosis?</span></span></p>",
      "unique_key": "Q8840712",
      "question_audio": null,
      "question_video": null,
      "map_id": 19798,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Renal cell carcinoma (RCC)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong> <strong><span style=\"font-size:12.0pt\">A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The image shows that erythrocytosis (increased red blood cell mass) can be a paraneoplastic syndrome associated with several cancers, with RCC being the most common at 3%. The patient&#39;s smoking history increases the risk of lung cancer, but the association with erythrocytosis is less strong.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hepatocellular carcinoma (HCC):</span></strong><span style=\"font-size:12.0pt\"> While HCC can also be associated with erythrocytosis, it&#39;s less common than RCC. Additionally, there&#39;s no mention of risk factors for HCC in this patient&#39;s history.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cerebellar hemangioblastoma:</span></strong><span style=\"font-size:12.0pt\"> Although hemangioblastomas can produce erythropoietin and cause erythrocytosis, they are much rarer than RCC and usually present with neurological symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Small cell lung cancer (SCLC):</span></strong><span style=\"font-size:12.0pt\"> SCLC is a possible cause of paraneoplastic erythrocytosis, but it&#39;s less common than RCC. The patient&#39;s smoking history increases the risk of lung cancer, but the absence of other respiratory symptoms makes it less likely in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythrocytosis can be a paraneoplastic manifestation of RCC, and appropriate evaluation is warranted in patients with unexplained erythrocytosis.</span></span></span></p>",
      "correct_choice_id": 79341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19846,
      "choices": [
        {
          "id": 79345,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Erythropoietin</span></span></span></p>"
        },
        {
          "id": 79346,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thrombopoietin</span></span></span></p>"
        },
        {
          "id": 79347,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vascular endothelial growth factor (VEGF)</span></span></span></p>"
        },
        {
          "id": 79348,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interleukin-6 (IL-6)</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 63-year-old woman presents to the emergency department with acute onset of left-sided weakness and slurred speech that began 2 hours ago. She also mentions experiencing a burning sensation in her palms and soles for the past month, which she attributed to her new gardening hobby. On examination, she has noticeable splenomegaly. Laboratory tests reveal a platelet count of 950,000/&mu;L, hemoglobin of 12.2 g/dL, and a white blood cell count of 7,800/&mu;L. A chest X-ray reveals a mass in the right lung hilum. Which protein is most likely responsible for this patient&#39;s thrombocytosis?</span></span></span></span></span></p>",
      "unique_key": "Q3191038",
      "question_audio": null,
      "question_video": null,
      "map_id": 19799,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">Ans. D) Interleukin-6 (IL-6)</span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">In this scenario, the patient presents with signs suggestive of a paraneoplastic syndrome associated with the underlying lung cancer (indicated by the mass in the right lung hilum). Paraneoplastic thrombocytosis is commonly seen in association with various malignancies, including lung cancer. Interleukin-6 (IL-6) is a cytokine that can be produced by tumor cells and is known to play a significant role in paraneoplastic thrombocytosis. IL-6 stimulates the liver to produce thrombopoietin, which in turn increases platelet production in the bone marrow.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">Explanation: </span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\"><strong>A.</strong> <strong>Erythropoietin:</strong> Primarily regulates red blood cell production and is more associated with polycythemia than thrombocytosis.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\"><strong>B.</strong> <strong>Thrombopoietin:</strong> Is the primary growth factor for platelet production. While it directly regulates platelet production, in the context of paraneoplastic thrombocytosis, it&#39;s the production of cytokines like IL-6 by the tumor that indirectly leads to increased thrombopoietin levels and subsequent thrombocytosis.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\"><strong>C.</strong> <strong>Vascular endothelial growth factor (VEGF</strong>): Is mainly involved in angiogenesis and not directly in the regulation of platelet production.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">Educational Objective:</span></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">Interleukin-6 (IL-6) can be produced by tumor cells and lead to paraneoplastic thrombocytosis in patients with malignancies such as lung cancer. IL-6 acts indirectly by stimulating the liver to produce more thrombopoietin, which then promotes increased platelet production in the bone marrow. Recognizing the role of IL-6 in paraneoplastic syndromes is important for understanding the systemic effects of certain cancers.</span></span></span></span></span></p>",
      "correct_choice_id": 79348,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}